Tuberculosis test kit 301031

for infectious diseasesfor identification analysisTB

For the purpose of distinguishing between MTB and NTM, the real-time fluorescent PCR and TaqMan probe technologies are utilized. This kit is the only CFDA-approved PCR assay for rapidly separating MTB cases from those caused by other mycobacterium species. Features of Mycobacteria Nucleic Acid Detection Get through all of the tests within 3 hours Both MTB and NTM can be detected with a single sample and test LoD of MTB is 10 bacteria/reaction, and the LoD of NTM is 100 bacteria/reaction Specificity is 98.9%, and detection rates for bacterial-positive and negative pulmonary tuberculosis are 97% and 24.4%, respectively Applicable Device of Mycobacteria Nucleic Acid Detection ABI 7700 real-time PCR system ABI 7500 real-time PCR system FQD-96A Fluorescent PCR Instrument Eppendorf ® Mastercycler ® ep real lex 4 S real-time PCR system Applications of Mycobacteria Nucleic Acid Detection Screening for tuberculosis quickly in people who may have it Differential Diagnosis for TB/NTM Diagnosis aid for TB in the lungs when bacteria are negative Diagnosing tuberculosis outside of the lungs High-risk populations for MTB/NTM infection detection include those in intimate contact with a smear-positive patient, those with HIV, those with diabetes, and those taking biologics/immunosuppressants. Studying the prevalence of disease